{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:18:13Z","timestamp":1787980693276,"version":"build-2784847793"},"reference-count":32,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.1620\/tjem.2025.j170","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T22:08:20Z","timestamp":1770242900000},"page":"421-434","source":"Crossref","is-referenced-by-count":0,"title":["Transcription Factor 21 Inhibits Prostate Cancer Progression via Transcriptional Repression of PSAT1"],"prefix":"10.1620","volume":"269","author":[{"given":"Shaoting","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Urinary Surgery, The Second Affiliated Hospital of Harbin Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urinary Surgery, The Second Affiliated Hospital of Harbin Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urinary Surgery, The Second Affiliated Hospital of Harbin Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Urinary Surgery, The Second Affiliated Hospital of Harbin Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"Abdallah, M.E., El-Readi, M.Z., Althubiti, M.A., Almaimani, R.A., Ismail, A.M., Idris, S., Refaat, B., Almalki, W.H., Babakr, A.T., Mukhtar, M.H., Abdalla, A.N.&amp;Idris, O.F. (2020)  Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells. <i>Molecules<\/i>, 25, 3355. https:\/\/doi.org\/10.3390\/molecules25153355","DOI":"10.3390\/molecules25153355"},{"key":"2","doi-asserted-by":"publisher","unstructured":"Aliyari, M., Hashemy, S.I., Hashemi, S.F., Reihani, A., Kesharwani, P., Hosseini, H.&amp;Sahebkar, A. (2024)  Targeting the Akt signaling pathway: Exploiting curcumin\u2019s anticancer potential. <i>Pathol. Res. Pract.<\/i>, 261, 155479. https:\/\/doi.org\/10.1016\/j.prp.2024.155479","DOI":"10.1016\/j.prp.2024.155479"},{"key":"3","doi-asserted-by":"publisher","unstructured":"Ao, X., Ding, W., Zhang, Y., Ding, D.&amp;Liu, Y. (2020)  TCF21: a critical transcription factor in health and cancer. <i>J. Mol. Med. <\/i>(<i>Berl.<\/i>), 98, 1055-1068. https:\/\/doi.org\/10.1007\/s00109-020-01934-7","DOI":"10.1007\/s00109-020-01934-7"},{"key":"4","doi-asserted-by":"publisher","unstructured":"Chen, L., Liu, H., Ji, Y., Ma, Z., Shen, K., Shangguan, X., Qian, H., Zhao, Y., Pan, C.W.&amp;Xue, W. (2022) Downregulation of SHMT2 promotes the prostate cancer proliferation and metastasis by inducing epithelial-mesenchymal transition. <i>Exp. Cell Res.<\/i>, 415, 113138. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113138","DOI":"10.1016\/j.yexcr.2022.113138"},{"key":"5","doi-asserted-by":"publisher","unstructured":"Cmero, M., Kurganovs, N.J., Stuchbery, R., McCoy, P., Grima, C., Ngyuen, A., Chow, K., Mangiola, S., Macintyre, G., Howard, N., Kerger, M., Dundee, P., Ruljancich, P., Clarke, D., Grummet, J., et al. (2021)  Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy. <i>JCO Precis. Oncol.<\/i>, 5, PO.20.00337. https:\/\/doi.org\/10.1200\/PO.20.00337","DOI":"10.1200\/PO.20.00337"},{"key":"6","doi-asserted-by":"publisher","unstructured":"Das, T.P., Suman, S., Papu John, A.M., Pal, D., Edwards, A., Alatassi, H., Ankem, M.K.&amp;Damodaran, C. (2016) Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer. <i>Cancer Lett.<\/i>, 377, 134-139. https:\/\/doi.org\/10.1016\/j.canlet.2016.04.028","DOI":"10.1016\/j.canlet.2016.04.028"},{"key":"7","doi-asserted-by":"publisher","unstructured":"Edmunds, K., Wang, Y., Sara, S., Riley, B., Heneka, N.&amp;Tuffaha, H. (2025)  Prostate Cancer Specialist Nursing Program: A Social Return on Investment Analysis Value for Money of the Prostate Cancer Specialist Nursing Program. <i>Psychooncology<\/i>, 34, e70181. https:\/\/doi.org\/10.1002\/pon.70181","DOI":"10.1002\/pon.70181"},{"key":"8","doi-asserted-by":"publisher","unstructured":"Feng, M., Cui, H., Tu, W., Li, L., Gao, Y., Chen, L., Li, D., Chen, X., Xu, F., Zhou, C.&amp;Cao, Y. (2022)  An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy. <i>Front. Genet.<\/i>, 13, 975381. https:\/\/doi.org\/10.3389\/fgene.2022.975381","DOI":"10.3389\/fgene.2022.975381"},{"key":"9","doi-asserted-by":"publisher","unstructured":"Galbraith, L., Leung, H.Y.&amp;Ahmad, I. (2018)  Lipid pathway deregulation in advanced prostate cancer. <i>Pharmacol. Res.<\/i>, 131, 177-184. https:\/\/doi.org\/10.1016\/j.phrs.2018.02.022","DOI":"10.1016\/j.phrs.2018.02.022"},{"key":"10","doi-asserted-by":"publisher","unstructured":"Hashemi, M., Taheriazam, A., Daneii, P., Hassanpour, A., Kakavand, A., Rezaei, S., Hejazi, E.S., Aboutalebi, M., Gholamrezaie, H., Saebfar, H., Salimimoghadam, S., Mirzaei, S., Entezari, M.&amp;Samarghandian, S. (2023)  Targeting PI3K\/Akt signaling in prostate cancer therapy. <i>J. Cell Commun. Signal.<\/i>, 17, 423-443. https:\/\/doi.org\/10.1007\/s12079-022-00702-1","DOI":"10.1007\/s12079-022-00702-1"},{"key":"11","doi-asserted-by":"publisher","unstructured":"Jamaspishvili, T., Berman, D.M., Ross, A.E., Scher, H.I., De Marzo, A.M., Squire, J.A.&amp;Lotan, T.L. (2018)  Clinical implications of PTEN loss in prostate cancer. <i>Nat. Rev. Urol.<\/i>, 15, 222-234. https:\/\/doi.org\/10.1038\/nrurol.2018.9","DOI":"10.1038\/nrurol.2018.9"},{"key":"12","doi-asserted-by":"publisher","unstructured":"Jie, H., Wei, J., Li, Z., Yi, M., Qian, X., Li, Y., Liu, C., Li, C., Wang, L., Deng, P., Liu, L., Cen, X.&amp;Zhao, Y. (2025)  Serine starvation suppresses the progression of esophageal cancer by regulating the synthesis of purine nucleotides and NADPH. <i>Cancer Metab.<\/i>, 13, 10. https:\/\/doi.org\/10.1186\/s40170-025-00376-4","DOI":"10.1186\/s40170-025-00376-4"},{"key":"13","doi-asserted-by":"publisher","unstructured":"Jin, C., Liao, S., Lu, G., Geng, B.D., Ye, Z., Xu, J., Ge, G.&amp;Yang, D. (2024)  Cellular senescence in metastatic prostate cancer: A therapeutic opportunity or challenge (Review). <i>Mol. Med. Rep.<\/i>, 30, 162. https:\/\/doi.org\/10.3892\/mmr.2024.13286","DOI":"10.3892\/mmr.2024.13286"},{"key":"14","doi-asserted-by":"publisher","unstructured":"Li, X., Wang, S., Nie, X., Hu, Y., Liu, O., Wang, Y.&amp;Lin, B. (2025)  PSAT1 regulated by STAT4 enhances the proliferation, invasion and migration of ovarian cancer cells via the PI3K\/AKT pathway. <i>Int. J. Mol. Med.<\/i>, 55, 88. https:\/\/doi.org\/10.3892\/ijmm.2025.5529","DOI":"10.3892\/ijmm.2025.5529"},{"key":"15","doi-asserted-by":"publisher","unstructured":"Liu, H., He, R., Yang, X., Huang, B.&amp;Liu, H. (2023)  Mechanism of TCF21 Downregulation Leading to Immunosuppression of Tumor-Associated Macrophages in Non-Small Cell Lung Cancer. <i>Pharmaceutics<\/i>, 15, 2295. https:\/\/doi.org\/10.3390\/pharmaceutics15092295","DOI":"10.3390\/pharmaceutics15092295"},{"key":"16","doi-asserted-by":"publisher","unstructured":"Liu, Y., Xu, X., Lin, P., He, Y., Zhang, Y., Cao, B., Zhang, Z., Sethi, G., Liu, J., Zhou, X.&amp;Mao, X. (2019)  Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis. <i>J. Biol. Chem.<\/i>, 294, 4572-4582. https:\/\/doi.org\/10.1074\/jbc.RA118.006057","DOI":"10.1074\/jbc.RA118.006057"},{"key":"17","doi-asserted-by":"publisher","unstructured":"Marrocco, I., Altieri, F., Rubini, E., Paglia, G., Chichiarelli, S., Giamogante, F., Macone, A., Perugia, G., Magliocca, F.M., Gurtner, A., Maras, B., Ragno, R., Patsilinakos, A., Manganaro, R.&amp;Eufemi, M. (2019)  Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism. <i>Cells<\/i>, 8, 1048. https:\/\/doi.org\/10.3390\/cells8091048","DOI":"10.3390\/cells8091048"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Martin-Caraballo, M.(2024)  Regulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer. <i>Int. J. Mol. Sci.<\/i>, 25, 4171. https:\/\/doi.org\/10.3390\/ijms25084171","DOI":"10.3390\/ijms25084171"},{"key":"19","doi-asserted-by":"publisher","unstructured":"Raychaudhuri, R., Lin, D.W.&amp;Montgomery, R.B. (2025)  Prostate Cancer: A Review. <i>JAMA<\/i>, 333, 1433-1446. https:\/\/doi.org\/10.1001\/jama.2025.0228","DOI":"10.1001\/jama.2025.0228"},{"key":"20","doi-asserted-by":"publisher","unstructured":"Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A.&amp;Mashele, S. (2022)  Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. <i>Molecules<\/i>, 27, 5730. https:\/\/doi.org\/10.3390\/molecules27175730","DOI":"10.3390\/molecules27175730"},{"key":"21","doi-asserted-by":"publisher","unstructured":"Silva, K.C.S., Tambwe, N., Mahfouz, D.H., Wium, M., Cacciatore, S., Paccez, J.D.&amp;Zerbini, L.F. (2024)  Transcription Factors in Prostate Cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches. <i>Genes<\/i> (<i>Basel<\/i>), 15, 450. https:\/\/doi.org\/10.3390\/genes15040450","DOI":"10.3390\/genes15040450"},{"key":"22","doi-asserted-by":"publisher","unstructured":"Tee, S.S., Suster, I., Truong, S., Jeong, S., Eskandari, R., DiGialleonardo, V., Alvarez, J.A., Aldeborgh, H.N.&amp;Keshari, K.R. (2018)  Targeted AKT Inhibition in Prostate Cancer Cells and Spheroids Reduces Aerobic Glycolysis and Generation of Hyperpolarized [1-(13)C] Lactate. <i>Mol. Cancer Res.<\/i>, 16, 453-460. https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0458","DOI":"10.1158\/1541-7786.MCR-17-0458"},{"key":"23","doi-asserted-by":"publisher","unstructured":"Toren, P.&amp;Zoubeidi, A. (2014)  Targeting the PI3K\/Akt pathway in prostate cancer: challenges and opportunities (review). <i>Int. J. Oncol.<\/i>, 45, 1793-1801. https:\/\/doi.org\/10.3892\/ijo.2014.2601","DOI":"10.3892\/ijo.2014.2601"},{"key":"24","doi-asserted-by":"publisher","unstructured":"Toson, B., Fortes, I.S., Roesler, R.&amp;Andrade, S.F. (2022)  Targeting Akt\/PKB in pediatric tumors: A review from preclinical to clinical trials. <i>Pharmacol. Res.<\/i>, 183, 106403. https:\/\/doi.org\/10.1016\/j.phrs.2022.106403","DOI":"10.1016\/j.phrs.2022.106403"},{"key":"25","doi-asserted-by":"publisher","unstructured":"Wang, M., Yue, S.&amp;Yang, Z. (2023)  Downregulation of PSAT1 inhibits cell proliferation and migration in uterine corpus endometrial carcinoma. <i>Sci. Rep.<\/i>, 13, 4081. https:\/\/doi.org\/10.1038\/s41598-023-31325-0","DOI":"10.1038\/s41598-023-31325-0"},{"key":"26","doi-asserted-by":"publisher","unstructured":"Whitlock, N.C., Trostel, S.Y., Wilkinson, S., Terrigino, N.T., Hennigan, S.T., Lake, R., Carrabba, N.V., Atway, R., Walton, E.D., Gryder, B.E., Capaldo, B.J., Ye, H.&amp;Sowalsky, A.G. (2020)  MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity. <i>Oncogene<\/i>, 39, 5663-5674. https:\/\/doi.org\/10.1038\/s41388-020-01389-7","DOI":"10.1038\/s41388-020-01389-7"},{"key":"27","doi-asserted-by":"publisher","unstructured":"Yang, X., Li, C.&amp;Chen, Y. (2023)  Phosphoserine Aminotransferase 1: A Metabolic Enzyme Target of Cancers. <i>Curr. Cancer Drug Targets<\/i>, 23, 171-186. https:\/\/doi.org\/10.2174\/1568009622666220829105300","DOI":"10.2174\/1568009622666220829105300"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Yang, Z., Chen, J.S., Wen, J.K., Gao, H.T., Zheng, B., Qu, C.B., Liu, K.L., Zhang, M.L., Gu, J.F., Li, J.D., Zhang, Y.P., Li, W., Wang, X.L.&amp;Zhang, Y. (2017)  Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel. <i>J. Exp. Clin. Cancer Res.<\/i>, 36, 178. https:\/\/doi.org\/10.1186\/s13046-017-0649-3","DOI":"10.1186\/s13046-017-0649-3"},{"key":"29","doi-asserted-by":"publisher","unstructured":"Yang, Z., Jiang, X., Li, D., Dong, Q., Zhao, H.&amp;Jiang, X. (2019)  TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer. <i>Gene<\/i>, 682, 42-49. https:\/\/doi.org\/10.1016\/j.gene.2018.10.011","DOI":"10.1016\/j.gene.2018.10.011"},{"key":"30","doi-asserted-by":"publisher","unstructured":"Ye, J., Huang, X., Tian, S., Wang, J., Wang, H., Feng, H., Zhao, X., Cao, S., Xuan, Y., Li, X., Ma, X., Huang, Y.&amp;Zhang, X. (2024)  Upregulation of serine metabolism enzyme PSAT1 predicts poor prognosis and promotes proliferation, metastasis and drug resistance of clear cell renal cell carcinoma. <i>Exp. Cell Res.<\/i>, 437, 113977. https:\/\/doi.org\/10.1016\/j.yexcr.2024.113977","DOI":"10.1016\/j.yexcr.2024.113977"},{"key":"31","doi-asserted-by":"publisher","unstructured":"Zhang, X., Wang, S., Li, W., Wang, J., Gong, Y., Chen, Q., Cao, S., Pang, D.&amp;Gao, S. (2024)  PSAT1 Promotes Metastasis via p-AKT\/SP1\/ITGA2 Axis in Estrogen Receptor-Negative Breast Cancer Cell. <i>Biomolecules<\/i>, 14, 990. https:\/\/doi.org\/10.3390\/biom14080990","DOI":"10.3390\/biom14080990"},{"key":"32","doi-asserted-by":"publisher","unstructured":"Zhou, X., Shen, K., Cao, S., Li, P., Xiao, J., Dong, J., Cheng, Q., Hu, L., Xu, Z.&amp;Yang, L. (2024)  Polymorphism rs2327430 in TCF21 predicts the risk and prognosis of gastric cancer by affecting the binding between TFAP2A and TCF21. <i>Cancer Cell Int.<\/i>, 24, 159. https:\/\/doi.org\/10.1186\/s12935-024-03343-z","DOI":"10.1186\/s12935-024-03343-z"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/3\/269_2025.J170\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:24:32Z","timestamp":1787977472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/3\/269_2025.J170\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j170","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025.J170"}}